Table 1.
Patients' demographic characteristics (N = 15), types of VHL lesions, and VHL mutations
| Characteristic | n (%) |
| Sex | |
| Male | 10 (67) |
| Female | 5 (33) |
| Median age (years) at treatment (range) | 36 (22–57) |
| VHL manifestation | No. of patients with lesions (%) |
| Renal cell carcinomas | 12 (80) |
| Renal cysts | 11 (73) |
| Hemangioblastomas | 11 (73) |
| Retinal hemangiomas | 9 (60) |
| Pancreatic cysts | 7 (47) |
| Pancreatic neuroendocrine tumors | 7 (47) |
| Adrenal lesions | 3 (20) |
| Endolymphatic sac tumor | 2 (13) |
| Epididymal cystadenoma | 1 (7) |
| VHL mutation | No. of patients with mutation |
| R167W | 3 |
| R177X | 2 |
| R167P | 1 |
| Deletion/truncation | 4 |
| P86A | 1 |
| Insertion R 88-89 | 1 |
| Y98D | 1 |
| X158 | 1 |
| N131K | 1 |
VHL, von Hippel–Lindau.